Pharmacological profile
The drug nadolol belongs to the class of non-selective $\beta$-adrenergic blockers. This means that its action is not limited exclusively to cardiac receptors (unlike cardioselective drugs), but extends to $\beta$-adrenergic receptors in various locations.
In its basic pharmacological properties and receptor-binding profile, the drug is very close to the reference non-selective $\beta$-blocker, propranolol. However, the key difference of nadolol is a significantly greater duration of clinical effect, which determines the specifics of its prescription.
Pharmacokinetics and administration
The prolonged action of the drug is due to its pharmacokinetic parameters. The half-life ($t_{1/2}$) of nadolol is from 20 to 24 hours.
Such a prolonged elimination profile provides an important practical advantage:
- The drug is prescribed in a dosing regimen of once daily.
- Absorption efficiency and the drug's action do not depend on food intake, which significantly improves patient adherence to treatment.
Indications for use
The spectrum of clinical application of nadolol covers both typical cardiological pathologies and endocrine disorders accompanied by hyperactivation of the sympathoadrenal system.
Key indications include:
- Arterial hypertension — for stable blood pressure reduction.
- Exertional angina — to reduce myocardial oxygen demand.
- Arrhythmias — to control and stabilize heart rhythm.
- Myocardial infarction — as part of combination therapy.
- Thyrotoxicosis — for relief of symptoms caused by excess thyroid hormones (tachycardia, tremor).
Briefly: answers to topical questions
How does nadolol differ from propranolol?
- Nadolol differs from propranolol in its duration of effect, low lipophilicity, and lack of membrane-stabilizing activity.
| Property | Nadolol | Propranolol |
|---|---|---|
| Lipophilicity | Low (hydrophilic) | High (+++) |
| Duration of effect | Long-acting | — |
| Membrane-stabilizing activity | Absent | Present |
You can remember the main difference between nadolol and its analog by the phonetic similarity: "NADOLOL is propranolol that works FOR A LONG TIME [RU: nadolgo] (24 hours)."
Class and exam questions
What group does nadolol belong to?
It is a long-acting non-selective $\beta$-adrenergic blocker.
What is the main difference between nadolol and propranolol?
Both drugs are non-selective $\beta$-blockers, but nadolol has a significantly longer duration of effect (half-life of 20–24 hours).
How does food intake affect nadolol dosing?
It has no effect. The drug is prescribed once daily regardless of food intake.
What else to study on this topic
- Mechanism of non-selective $\beta_1$- and $\beta_2$-adrenergic receptor blockade
- Comparative profile of propranolol and nadolol
- The role of $\beta$-adrenergic blockers in relieving symptoms of thyrotoxicosis
- Pathogenesis of exertional angina and the sites of action of nadolol
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Nadolol" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs Acting on Adrenergic Synapses"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.